@

초록

National efforts to enhance the readability and utilization of drug labeling information are ongoing, emphasizingthe pivotal role of effective systems influenced by regulatory frameworks. A comparative analysis of drug labelingsubmissions within the administrative context of Module 1 of the Common Technical Document revealed the potential todiscern disparities in managing drug labeling information across distinct nations. Consequently, this study scrutinized thestructure of drug labeling submissions in Module 1 within the jurisdictions of Korea, the United States, and Europe. Significantly, the United States and Europe require data assessing the consumer’s understanding of drug labeling, subjectto regulatory review. In contrast, the Korean regulatory framework overlooks audience considerations and lacks dataevaluating labeling appropriateness. These differing submission practices result in significant disparities in drug labelingcontent and format. Regulatory specifications heavily shape drug labeling, leading to differences in the depth of oversightdue to submission format disparities. While the administrative content encompassed within Module 1 of the CommonTechnical Document acknowledges national discrepancies, we aspire to establish a more sophisticated and consumer-centricdrug-labeling system in Korea.

키워드